PROMETHEUS BIOSCIENCES INC (RXDX)

US74349U1088 - Common Stock

199.92  +0.18 (+0.09%)

After market: 199.95 +0.03 (+0.02%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-3-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
4.00M6.81M3.13M1.23M1.12M
Operating Expenses
166.38M152.59M90.93M30.24M17.09M
Research and Development
121.36M112.85M62.43M19.15M10.96M
Selling, General, and Administrative Expenses
45.02M39.74M28.50M11.09M6.13M
Operating Income
-162.38M-145.78M-87.80M-29.01M-15.97M
Interest Income/Expense
11.82M4.03M-753.00K-2.12M-760.00K
Other Income/Expense
N/A0.00-1.08M-20.00K0.00
Non Recurring Items
N/A0.00-554.00KN/AN/A
Income Before Taxes
-150.56M-141.75M-90.19M-31.14M-16.73M
Income Tax
N/AN/AN/AN/AN/A
Net Income
-150.56M-141.75M-90.19M-37.14M-29.72M
EBITDA
-161.61M-145.15M-87.55M-28.90M-15.93M
 
Per Share Data
EPS Diluted Total Ops
-3.52-3.49-2.88-0.99-0.79
Non GAAP EPS
-3.52-3.48-3.63N/AN/A
 
Statistics
Profit Margin
-3768.76%-2081.83%-2882.55%-3019.51%-2653.57%
Operating Profit Margin
-4064.71%-2140.96%-2806.10%-2358.54%-1425.89%

All data in USD

Charts